This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2011 Aug 1;10(8):571-2.

doi: 10.1038/nrd3515.

The Parkinson's disease market

PMID: 21808232
DOI: 10.1038/nrd3515

The Parkinson's disease market

Trung Huynh. Nat Rev Drug Discov. 2011.

. 2011 Aug 1;10(8):571-2.

doi: 10.1038/nrd3515.

Author

PMID: 21808232
DOI: 10.1038/nrd3515

No abstract available

PubMed Disclaimer

Similar articles

Levodopa, ayurveda and Parkinson's disease.
Deleu D, Hanssens Y, Northway MG. Deleu D, et al. J Neurol Sci. 2001 Feb 15;184(1):89-92. doi: 10.1016/s0022-510x(00)00499-8. J Neurol Sci. 2001. PMID: 11305284 No abstract available.
Levodopa treatment in Parkinson's disease: how does it affect dysphagia management?
Nóbrega AC, Pinho P, Deiró M, Argolo N. Nóbrega AC, et al. Parkinsonism Relat Disord. 2014 Mar;20(3):340-1. doi: 10.1016/j.parkreldis.2013.09.013. Epub 2013 Sep 20. Parkinsonism Relat Disord. 2014. PMID: 24094704 No abstract available.
The neurochemistry of therapeutics: levodopa pharmacodynamics in Parkinson's disease.
Frey KA. Frey KA. Ann Neurol. 2001 Mar;49(3):285-7. Ann Neurol. 2001. PMID: 11261500 No abstract available.
Levodopa: management of Parkinson's disease.
[No authors listed] [No authors listed] Mov Disord. 2002;17 Suppl 4:S23-37. doi: 10.1002/mds.5558. Mov Disord. 2002. PMID: 12211137 Review. No abstract available.
Levodopa therapeutics for Parkinson's disease: new developments.
LeWitt PA. LeWitt PA. Parkinsonism Relat Disord. 2009 Jan;15 Suppl 1:S31-4. doi: 10.1016/S1353-8020(09)70009-4. Parkinsonism Relat Disord. 2009. PMID: 19131040 Review.

See all similar articles

Cited by

Amelioration of Mitochondrial Quality Control and Proteostasis by Natural Compounds in Parkinson's Disease Models.
Cho B, Kim T, Huh YJ, Lee J, Lee YI. Cho B, et al. Int J Mol Sci. 2019 Oct 21;20(20):5208. doi: 10.3390/ijms20205208. Int J Mol Sci. 2019. PMID: 31640129 Free PMC article. Review.
Molecular Mechanism of Regulation of MTA1 Expression by Granulocyte Colony-stimulating Factor.
Kumar AS, Jagadeeshan S, Subramanian A, Chidambaram SB, Surabhi RP, Singhal M, Bhoopalan H, Sekar S, Pitani RS, Duvuru P, Venkatraman G, Rayala SK. Kumar AS, et al. J Biol Chem. 2016 Jun 3;291(23):12310-21. doi: 10.1074/jbc.M115.707224. Epub 2016 Apr 4. J Biol Chem. 2016. PMID: 27044752 Free PMC article.
In vitro pharmacological profile of the A2A receptor antagonist istradefylline.
Saki M, Yamada K, Koshimura E, Sasaki K, Kanda T. Saki M, et al. Naunyn Schmiedebergs Arch Pharmacol. 2013 Nov;386(11):963-72. doi: 10.1007/s00210-013-0897-5. Epub 2013 Jun 29. Naunyn Schmiedebergs Arch Pharmacol. 2013. PMID: 23812646
Chronic Inflammation Links Cancer and Parkinson's Disease.
Li Z, Zheng Z, Ruan J, Li Z, Tzeng CM. Li Z, et al. Front Aging Neurosci. 2016 Jun 3;8:126. doi: 10.3389/fnagi.2016.00126. eCollection 2016. Front Aging Neurosci. 2016. PMID: 27375474 Free PMC article. Review.
Emerging preclinical pharmacological targets for Parkinson's disease.
More SV, Choi DK. More SV, et al. Oncotarget. 2016 May 17;7(20):29835-63. doi: 10.18632/oncotarget.8104. Oncotarget. 2016. PMID: 26988916 Free PMC article. Review.

See all "Cited by" articles

References

1. N Engl J Med. 2009 Sep 24;361(13):1268-78 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information